Navigation Links
CT-guided irreversible electroporation safe in unresectable pancreatic carcinoma
Date:5/7/2014

Leesburg, VA, May 6, 2014A small group of patients with locally advanced unresectable pancreatic carcinoma suffered no major ill effectspancreatitis or fistula formationafter undergoing percutaneous CT-guided irreversible electroporation (IRE)a nonthermal ablation technology that is safe near vascular and ductal structuresas a therapy.

"Our findings exceeded our expectations," said Maria Paola Belfiore, a researcher at the Institute of Radiology, Second University of Naples. "In fact, three patients were downstaged, and so had a greater life expectancy. This is a great new promise for inoperable pancreatic tumors."

The ablation procedure was successful in 100 percent of the patients. These early results represent a good alternative to intraoperative IRE ablation, and offer a safe and feasible primary local treatment for locally advanced pancreatic cancer.


'/>"/>

Contact: Lissa D. Hurwitz
lhurwitz@arrs.org
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Vaginal Mesh Lawsuit Filed by Wright & Schulte LLC on Behalf of a Nebraska Woman Alleging Her Irreversible Injuries Were Caused by Boston Scientific’s Transvaginal Mesh
2. Transvaginal Mesh Lawsuit Filed by Wright & Schulte Alleges that Boston Scientific’s Defective Mesh Sling Caused New York Woman to Suffer Serious, Irreversible Injuries
3. Transvaginal Mesh Lawsuit Filed by Wright & Schulte LLC on Behalf of Michigan Woman Alleging the Defective Design of Ethicon’s Mesh Sling Caused Irreversible Injuries
4. Study: Ipilimumab Shows Durable Responses But Low Overall Response Rate In Patients With Unresectable Or Metastatic Mucosal Melanoma
5. Short Walks May Ease Fatigue in Pancreatic Cancer Patients
6. Mutant Kras drives pancreatic cancer maintenance via metabolic pathways
7. Early biomarker for pancreatic cancer identified
8. Researchers present new findings for novel pancreatic cancer vaccine
9. Studies See Advances in Detecting, Treating Pancreatic Cancer
10. Nerve growth factors elevated in pancreatic cancer model
11. Sun exposure and sun-sensitive skin type decreased risk for pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... , ... Mediaplanet is proud to announce the launch of its newest edition ... readers on how to take care of all aspects of their skin. , On ... Dancing with the Stars professional, Witney Carson, shares her journey with the disease that ...
(Date:5/26/2017)... ... May 26, 2017 , ... The Radiology Business Management ... on current legislative activity and the latest regulatory concerns impacting RBMA members. The ... 10, and will continue through Monday, Sept. 11, at the Ritz-Carlton, Tysons Corner ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community health ... seniors are located in the Midwest. With the average cost of healthcare rising and ... concerned with both the quality and affordability of where they live. An annual 2017 ...
(Date:5/26/2017)... ... 26, 2017 , ... On May 24, the Congressional Budget Office (CBO) projected ... on May 4, would result in 23 million Americans losing their health insurance by ... Patient Protection and Affordable Care Act (ACA). , “It is clear from the ...
(Date:5/26/2017)... ... ... Silver Birch of Hammond, a new assisted lifestyle community, has welcomed its first ... at 5620 Sohl Avenue in Hammond, serves older adults who need some help to ... apartments. Each of the private apartments at Silver Birch features a kitchenette, spacious bathroom ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)... PLEASANTON, Calif. , May 23, 2017 /PRNewswire/ ... world,s most innovative medical devices for pressure ulcer ... at the American Association of Critical Care Nurses, ... Houston May 22-25. The Leaf Patient ... designed specifically for the hospital environment.  The system ...
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/11/2017)...  Thornhill Research Inc. ( Toronto, Ontario, ... USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the U.S. ... (CCC) ( Ottawa, Ontario, Canada ) ... anesthesia to patients requiring emergency medical procedures in ... Corps have been a longtime partner with Thornhill ...
Breaking Medicine Technology: